222 related articles for article (PubMed ID: 19834332)
1. Inhibition of soluble epoxide hydrolase by trans-4- [4-(3-adamantan-1-yl-ureido)-cyclohexyloxy]-benzoic acid is protective against ischemia-reperfusion injury.
Chaudhary KR; Abukhashim M; Hwang SH; Hammock BD; Seubert JM
J Cardiovasc Pharmacol; 2010 Jan; 55(1):67-73. PubMed ID: 19834332
[TBL] [Abstract][Full Text] [Related]
2. Soluble epoxide hydrolase inhibition and gene deletion are protective against myocardial ischemia-reperfusion injury in vivo.
Motoki A; Merkel MJ; Packwood WH; Cao Z; Liu L; Iliff J; Alkayed NJ; Van Winkle DM
Am J Physiol Heart Circ Physiol; 2008 Nov; 295(5):H2128-34. PubMed ID: 18835921
[TBL] [Abstract][Full Text] [Related]
3. Soluble epoxide hydrolase inhibitor trans-4-[4-(3-adamantan-1-yl-ureido)-cyclohexyloxy]-benzoic acid is neuroprotective in rat model of ischemic stroke.
Shaik JS; Ahmad M; Li W; Rose ME; Foley LM; Hitchens TK; Graham SH; Hwang SH; Hammock BD; Poloyac SM
Am J Physiol Heart Circ Physiol; 2013 Dec; 305(11):H1605-13. PubMed ID: 24043255
[TBL] [Abstract][Full Text] [Related]
4. Novel soluble epoxide hydrolase inhibitor protects mitochondrial function following stress.
Batchu SN; Lee SB; Samokhvalov V; Chaudhary KR; El-Sikhry H; Weldon SM; Seubert JM
Can J Physiol Pharmacol; 2012 Jun; 90(6):811-23. PubMed ID: 22624559
[TBL] [Abstract][Full Text] [Related]
5. Cardioprotective effect of a dual acting epoxyeicosatrienoic acid analogue towards ischaemia reperfusion injury.
Batchu SN; Lee SB; Qadhi RS; Chaudhary KR; El-Sikhry H; Kodela R; Falck JR; Seubert JM
Br J Pharmacol; 2011 Feb; 162(4):897-907. PubMed ID: 21039415
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of soluble epoxide hydrolase by cis-4-[4-(3-adamantan-1-ylureido)cyclohexyl-oxy]benzoic acid exhibits antihypertensive and cardioprotective actions in transgenic rats with angiotensin II-dependent hypertension.
Neckář J; Kopkan L; Husková Z; Kolář F; Papoušek F; Kramer HJ; Hwang SH; Hammock BD; Imig JD; Malý J; Netuka I; Ošťádal B; Červenka L
Clin Sci (Lond); 2012 Jun; 122(11):513-25. PubMed ID: 22324471
[TBL] [Abstract][Full Text] [Related]
7. Soluble epoxide hydrolase inhibition improves coronary endothelial function and prevents the development of cardiac alterations in obese insulin-resistant mice.
Roche C; Besnier M; Cassel R; Harouki N; Coquerel D; Guerrot D; Nicol L; Loizon E; Remy-Jouet I; Morisseau C; Mulder P; Ouvrard-Pascaud A; Madec AM; Richard V; Bellien J
Am J Physiol Heart Circ Physiol; 2015 May; 308(9):H1020-9. PubMed ID: 25724490
[TBL] [Abstract][Full Text] [Related]
8. Role of soluble epoxide hydrolase in postischemic recovery of heart contractile function.
Seubert JM; Sinal CJ; Graves J; DeGraff LM; Bradbury JA; Lee CR; Goralski K; Carey MA; Luria A; Newman JW; Hammock BD; Falck JR; Roberts H; Rockman HA; Murphy E; Zeldin DC
Circ Res; 2006 Aug; 99(4):442-50. PubMed ID: 16857962
[TBL] [Abstract][Full Text] [Related]
9. Role of haem oxygenase in the renoprotective effects of soluble epoxide hydrolase inhibition in diabetic spontaneously hypertensive rats.
Elmarakby AA; Faulkner J; Pye C; Rouch K; Alhashim A; Maddipati KR; Baban B
Clin Sci (Lond); 2013 Oct; 125(7):349-59. PubMed ID: 23611540
[TBL] [Abstract][Full Text] [Related]
10. Inhibitors of soluble epoxide hydrolase minimize ischemia-reperfusion-induced cardiac damage in normal, hypertensive, and diabetic rats.
Islam O; Patil P; Goswami SK; Razdan R; Inamdar MN; Rizwan M; Mathew J; Inceoglu B; Stephen Lee KS; Hwang SH; Hammock BD
Cardiovasc Ther; 2017 Jun; 35(3):. PubMed ID: 28296232
[TBL] [Abstract][Full Text] [Related]
11. Role of B-type natriuretic peptide in epoxyeicosatrienoic acid-mediated improved post-ischaemic recovery of heart contractile function.
Chaudhary KR; Batchu SN; Das D; Suresh MR; Falck JR; Graves JP; Zeldin DC; Seubert JM
Cardiovasc Res; 2009 Jul; 83(2):362-70. PubMed ID: 19401302
[TBL] [Abstract][Full Text] [Related]
12. Adenosine A2A receptor modulates vascular response in soluble epoxide hydrolase-null mice through CYP-epoxygenases and PPARγ.
Nayeem MA; Pradhan I; Mustafa SJ; Morisseau C; Falck JR; Zeldin DC
Am J Physiol Regul Integr Comp Physiol; 2013 Jan; 304(1):R23-32. PubMed ID: 23152114
[TBL] [Abstract][Full Text] [Related]
13. Differential effects of soluble epoxide hydrolase inhibition and CYP2J2 overexpression on postischemic cardiac function in aged mice.
Chaudhary KR; Zordoky BN; Edin ML; Alsaleh N; El-Kadi AO; Zeldin DC; Seubert JM
Prostaglandins Other Lipid Mediat; 2013; 104-105():8-17. PubMed ID: 22922020
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetic optimization of four soluble epoxide hydrolase inhibitors for use in a murine model of inflammation.
Liu JY; Tsai HJ; Hwang SH; Jones PD; Morisseau C; Hammock BD
Br J Pharmacol; 2009 Jan; 156(2):284-96. PubMed ID: 19154430
[TBL] [Abstract][Full Text] [Related]
15. Soluble epoxide hydrolase gene deficiency or inhibition attenuates chronic active inflammatory bowel disease in IL-10(-/-) mice.
Zhang W; Yang AL; Liao J; Li H; Dong H; Chung YT; Bai H; Matkowskyj KA; Hammock BD; Yang GY
Dig Dis Sci; 2012 Oct; 57(10):2580-91. PubMed ID: 22588244
[TBL] [Abstract][Full Text] [Related]
16. Soluble epoxide hydrolase: a new target for cardioprotection.
Gross GJ; Nithipatikom K
Curr Opin Investig Drugs; 2009 Mar; 10(3):253-8. PubMed ID: 19333883
[TBL] [Abstract][Full Text] [Related]
17. Linoleic Acid Metabolite DiHOME Decreases Post-ischemic Cardiac Recovery in Murine Hearts.
Bannehr M; Löhr L; Gelep J; Haverkamp W; Schunck WH; Gollasch M; Wutzler A
Cardiovasc Toxicol; 2019 Aug; 19(4):365-371. PubMed ID: 30725262
[TBL] [Abstract][Full Text] [Related]
18. Soluble epoxide hydrolase inhibitors, t-AUCB, downregulated miR-133 in a mouse model of myocardial infarction.
Gui Y; Li D; Chen J; Wang Y; Hu J; Liao C; Deng L; Xiang Q; Yang T; Du X; Zhang S; Xu D
Lipids Health Dis; 2018 May; 17(1):129. PubMed ID: 29843720
[TBL] [Abstract][Full Text] [Related]
19. Role of soluble epoxide hydrolase in exacerbation of stroke by streptozotocin-induced type 1 diabetes mellitus.
Jouihan SA; Zuloaga KL; Zhang W; Shangraw RE; Krasnow SM; Marks DL; Alkayed NJ
J Cereb Blood Flow Metab; 2013 Oct; 33(10):1650-6. PubMed ID: 23899929
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of soluble epoxide hydrolase in mice promotes reverse cholesterol transport and regression of atherosclerosis.
Shen L; Peng H; Peng R; Fan Q; Zhao S; Xu D; Morisseau C; Chiamvimonvat N; Hammock BD
Atherosclerosis; 2015 Apr; 239(2):557-65. PubMed ID: 25733327
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]